Jan A. van Mourik

11.3k total citations
172 papers, 9.2k citations indexed

About

Jan A. van Mourik is a scholar working on Hematology, Genetics and Immunology and Allergy. According to data from OpenAlex, Jan A. van Mourik has authored 172 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hematology, 37 papers in Genetics and 30 papers in Immunology and Allergy. Recurrent topics in Jan A. van Mourik's work include Platelet Disorders and Treatments (79 papers), Blood Coagulation and Thrombosis Mechanisms (68 papers) and Hemophilia Treatment and Research (46 papers). Jan A. van Mourik is often cited by papers focused on Platelet Disorders and Treatments (79 papers), Blood Coagulation and Thrombosis Mechanisms (68 papers) and Hemophilia Treatment and Research (46 papers). Jan A. van Mourik collaborates with scholars based in Netherlands, United Kingdom and United States. Jan A. van Mourik's co-authors include Koen Mertens, Jan Voorberg, Peter J. Lenting, Daniel A. Lawrence, David J. Loskutoff, Hans Pannekoek, Philip G. de Groot, W.G. van Aken, Thalia Romani de Wit and Anton Jan van Zonneveld and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jan A. van Mourik

171 papers receiving 8.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan A. van Mourik Netherlands 55 5.7k 1.9k 1.6k 1.6k 1.3k 172 9.2k
Simon Karpatkin United States 55 5.9k 1.0× 1.7k 0.9× 1.4k 0.9× 1.3k 0.8× 1.0k 0.8× 206 9.8k
Jan J. Sixma Netherlands 43 4.1k 0.7× 2.0k 1.1× 799 0.5× 1.1k 0.7× 802 0.6× 155 7.7k
Yale Nemerson United States 58 7.9k 1.4× 2.2k 1.2× 2.2k 1.4× 1.6k 1.0× 1.1k 0.9× 145 12.7k
Dan Eaton United States 43 5.3k 0.9× 2.5k 1.4× 1.8k 1.1× 3.1k 1.9× 1.8k 1.4× 76 11.7k
Jerry Ware United States 50 5.2k 0.9× 2.0k 1.1× 801 0.5× 1.4k 0.9× 460 0.4× 148 8.4k
Yoshiaki Tomiyama Japan 49 3.6k 0.6× 2.0k 1.1× 828 0.5× 2.0k 1.3× 444 0.4× 275 8.3k
Kenneth Kaushansky United States 61 7.6k 1.3× 3.8k 2.0× 3.1k 1.9× 2.9k 1.8× 611 0.5× 210 12.9k
Perumal Thiagarajan United States 43 2.7k 0.5× 2.9k 1.5× 484 0.3× 1.2k 0.8× 776 0.6× 138 7.5k
Wolfram Ruf United States 70 9.1k 1.6× 4.0k 2.1× 3.5k 2.2× 2.4k 1.5× 2.2k 1.7× 280 15.7k
Jing-fei Dong United States 44 3.3k 0.6× 1.3k 0.7× 703 0.4× 2.0k 1.3× 554 0.4× 85 6.9k

Countries citing papers authored by Jan A. van Mourik

Since Specialization
Citations

This map shows the geographic impact of Jan A. van Mourik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan A. van Mourik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan A. van Mourik more than expected).

Fields of papers citing papers by Jan A. van Mourik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan A. van Mourik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan A. van Mourik. The network helps show where Jan A. van Mourik may publish in the future.

Co-authorship network of co-authors of Jan A. van Mourik

This figure shows the co-authorship network connecting the top 25 collaborators of Jan A. van Mourik. A scholar is included among the top collaborators of Jan A. van Mourik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan A. van Mourik. Jan A. van Mourik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laat, Bas de, Carel M. Eckmann, Jan Michiels, et al.. (2009). A Novel Type 2A von Willebrand Factor Mutation (V1499E) Associated With Variable Clinical Expression. Journal of Pediatric Hematology/Oncology. 31(4). 277–280. 6 indexed citations
2.
Bierings, Ruben, Maartje van den Biggelaar, Astrid Kragt, et al.. (2007). Efficiency of von Willebrand factor‐mediated targeting of interleukin‐8 into Weibel–Palade bodies. Journal of Thrombosis and Haemostasis. 5(12). 2512–2519. 27 indexed citations
3.
Luken, Brenda M., Paul Kaijen, Ellen A.M. Turenhout, et al.. (2006). Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 4(11). 2355–2364. 58 indexed citations
4.
Bouma, Bonno N. & Jan A. van Mourik. (2006). Unraveling the mystery of von Willebrand factor. Journal of Thrombosis and Haemostasis. 4(3). 489–495. 3 indexed citations
5.
Hollestelle, Martine J., Srabasti J. Chakravorty, Alister Craig, et al.. (2006). von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. British Journal of Haematology. 133(5). 562–569. 105 indexed citations
6.
Voorberg, Jan, Mariska G. Rondaij, Ruben Bierings, et al.. (2005). The Guanine Exchange Factor RalGDS Is Involved in Regulated Exocytosis of Weibel-Palade Bodies from Endothelial Cells.. Blood. 106(11). 3688–3688. 1 indexed citations
7.
Wit, Thalia Romani de, et al.. (2003). Von Willebrand factor targets IL-8 to Weibel–Palade bodies in an endothelial cell line. Experimental Cell Research. 286(1). 67–74. 27 indexed citations
8.
Wit, Thalia Romani de & Jan A. van Mourik. (2001). Biosynthesis, processing and secretion of von Willebrand factor: biological implications. Best Practice & Research Clinical Haematology. 14(2). 241–255. 50 indexed citations
9.
Fernandez‐Borja, Mar, Eric A. Reits, Thalia Romani de Wit, et al.. (2001). Small GTP-Binding Protein Ral Modulates Regulated Exocytosis of von Willebrand Factor by Endothelial Cells. Arteriosclerosis Thrombosis and Vascular Biology. 21(6). 899–904. 38 indexed citations
10.
Lenting, Peter J., Jaap G. Neels, Birgit M.M. van den Berg, et al.. (1999). The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein. Journal of Biological Chemistry. 274(34). 23734–23739. 170 indexed citations
11.
Fontijn, Ruud D., et al.. (1997). Polarity of Constitutive and Regulated von Willebrand Factor Secretion by Transfected MDCK-II Cells. Experimental Cell Research. 230(2). 352–361. 14 indexed citations
12.
13.
Montaruli, Barbara, et al.. (1996). Arterial and venous thrombosis in two Italian families with the factor V Arg506→ Gln mutation. European Journal Of Haematology. 57(1). 96–100. 3 indexed citations
14.
Mertens, Koen, et al.. (1994). The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes. British Journal of Haematology. 87(2). 332–342. 41 indexed citations
15.
Poot, A.A., A. Dekker, Jan A. van Mourik, et al.. (1991). Promotion of endothelial coverage and decrease of platelet reactivity of artificial surfaces using monoclanal antibodies directed against endothelial cells. Thrombosis and Haemostasis. 65. 65–65. 3 indexed citations
16.
Dekker, A., A.A. Poot, Jan A. van Mourik, et al.. (1991). Improved Adhesion and Proliferation of Human Endothelial Cells on Polyethylene Precoated with Monoclonal Antibodies Directed against Cell Membrane Antigens and Extracellular Matrix Proteins. Thrombosis and Haemostasis. 66(6). 715–724. 22 indexed citations
17.
Giltay, Jacques C., et al.. (1990). The platelet glycoprotein Ia‐IIa‐associated Br‐alloantigen system is expressed by cultured endothelial cells. British Journal of Haematology. 75(4). 557–560. 22 indexed citations
18.
Vervoorn, Richard C., et al.. (1987). Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution. Journal of Cellular Physiology. 133(1). 79–87. 30 indexed citations
19.
20.
Bakker, J., et al.. (1982). Bradykinin-mediated hypotension after infusion of plasma-protein fraction.. PubMed. 100(2). 288–95. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Karpatkin Breakdown of academic impact, for papers by Jan J. Sixma Breakdown of academic impact, for papers by Yale Nemerson Breakdown of academic impact, for papers by Dan Eaton Breakdown of academic impact, for papers by Jerry Ware Breakdown of academic impact, for papers by Yoshiaki Tomiyama Breakdown of academic impact, for papers by Kenneth Kaushansky Breakdown of academic impact, for papers by Perumal Thiagarajan Breakdown of academic impact, for papers by Wolfram Ruf Breakdown of academic impact, for papers by Jing-fei Dong
Rankless by CCL
2026